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Human lactate dehydrogenase is a tetramer made up of two types
ofsubunits, either H (heart) orM (muscle). Combination of these
subunits gives rise to the five isoenzymes of lactate dehydrogenase
which are found in mammalian tissues. The relative proportions
of the individual isoenzymesfound in serum ofpatients is related
to the severity of the lesion in the organ or tissuefrom which they
originate and the half-life of the individual tissue-specific enzymes.
Thus, one cannot predict the relative proportions of the different
isoenzymes in any one patient sample.
Lactate dehydrogenase catalyses the reversible oxidation of lactate
to pyruvate and either reaction can be measured readily. However,
in this method, the lactate to pyruvate reaction has been selected
because of thefollowing reasons; the time-course of the reaction is
more linear, the reaction results in an increase in absorbance and
optimization of substrates is possible (see appendix A).
The principles applied in the selection of the conditions of
measurement are those stated in previous publications by the IFCC’s
Committee on Enzymes [1]. Human serum and tissue extracts have
been used as the sources of enzymes. The final concentration of
substrates and thepH have been selected on the basis ofexperiments
and empirical optimization techniques and have been confirmed by
calculation from rate equations. The catalytic and physical
properties of the isoenzymes differ, but because of the importance of
the heart specific isoenzyme (LD1) in the assessment of coronary
heart disease and as a turnout marker, this method has been
optimizedfor this isoenzyme. However, the method is also suitable,
although less optimally, for the determination of the other
isoenzymes oflactate dehydrogenase which may bepresent in serum.
Principle
The proposed method for the measurement ofthe catalytic
concentration of lactate dehydrogenase in serum is based
on the principles outlined by Wacker et al. [2] and
Vanderlinde [3]. Modifications include optimization of
the substrate concentrations and pH and the choice of
N-methyl-D-glucamine as the buffer.
The reversible reaction catalysed by lactate dehydrogenase
To whom correspondence should be addressed.
is as follows"
L( + )-lactate+NAD + <=> pyruvate + H
/ +NADH (1)
The reaction is monitored by following the reduction of
NAD
/ at 339 nm. The equilibrium favours the tbrmation
of pyruvate at pH values greater than 9. The enzyme
exhibits absolute specificity for the L( + isomer. L( + )-
-Hydroxybutyrate is also a substrate as are some of the
higher -hydroxy acids [4].
Optimal conditions for measurement
These IFCC conditions are optimized reaction conditions
which are defined [1] as those conditions that are most
favourable for both the kinetic reactions and the technical
aspects of the measurement, i.e. these conditions do not
necessarily provide maximum activity.
The reaction is initiated by the addition of NAD
/
Temperature 30"00 __+ 0"05C
pU (30C) 9"40 ___
0"05
N-Methyl-D-glucamine 325 mmol/1
L( + )-Lactate 50 mmol/1
Volume fraction of sample 0"05 "21)
NAD
/ 10 mmol/1
Instrumentation and equipment
A recording spectrophotometer suitable for accurate
measurements at the wavelength of 339nm with a
constant temperature cuvette compartment must be used.
The specifications for the equipment (spectral band width,
light path, accuracy of temperature) should meet those
of previous recommendations [ 1].
Reagents
(1) N-methyl-D-glucamine, CTH 7NO5, Mr 195.22.
(2) L( + )-Lactic acid; lithium salt, C3HsO3Li, Mr96"01.
(3) /- Nicotinamide- adenine dinucleotide, ti’ee acid
(NAD+), C21H27NTO1P2, Mr 663-4.
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(4) Hydrochloric acid, HC1, Mr 36.46 (1 mol/1 and
5 mol/1).
(5) Sodium chloride, NaC1, Mr 58"44 (150 mmol/1).
Purity of reagents
The assessment of reagent purity is made on the basis
of functional (performance of reagent), chemical (analyt-
ical evaluation) and instrumental (absorbance or fluores-
cence) characteristics.
To prevent the growth of microorganisms in solutions,
sterilized containers should be used. All solutions should
be prepared in calibrated flasks with water meeting the
tbllowing standards [5]: electrical resistivity: > 2"0 x 104
ohm m at 25C; pH: 6’0-7"0; and silicates <0"1 mg/1.
Specimen procurement and stability
Serum is the preferred specimen. Plasma may be con-
taminated with platelets which contain high concentra-
tions of lactate dehydrogenase and should be avoided.
Collect blood by venipuncture with minimal manipula-
tion and stasis. Avoid haemolysis to minimize interference
by erthrocyte lactate dehydrogenase. Cell-free serum
should be obtained by centrifuging clotted blood for
10 min at a relative centrifugal force of approximately
1000 g.
The stability of the lactate dehydrogenase isoenzymes
varies [6].
Measurement
Preparation of solutions
(I) Buffer. N-methyl-D-glucamine buffer (379"2 mmol/1,
pH 9"4 at 30C)
Dissolve 74"03 g N-methyl-D-glucamine in ap-
proximately 800 mL water, adjust pH to 9"4 at
30C with HC1. Adjust the volume to 1000 mL
with water.
(II) Buffered Substrate solution. N-methyl-D-glucamine/
lithium lactate (N-methyl-D-glucamine buffer 379"2
mmol/1, pH 9"4 containing 58"3 mmol/1 lithium
lactate).
Transir 80 mL of N-methyl-D-glucamine buffer
solution I to a 100 ml beaker containing a magnetic
stirrer. Dissolve with stirring at room temperature,
lactic acid, lithium salt, 0"560 g. Adjust the pH, if
necessary, to 9.4 at 30C with HC1, mol/1.
Transir the solution to a 100 ml volumetric flask
and add N-methyl-D-glucamine buffer solution I
to a final volume of exactly 100 ml.
(III) Reagent solution NAD+/water (NAD +, 105 mmol/1
in water).
Dissolve 0"697 g ofNAD + in 8 ml of distilled water
in a 10 ml volumetric flask. When dissolved add
water to a final volume of exactly 10 ml.
(IV) Solution of sodium chloride (154 mmol/1).
Dissolve 0"9 g ofsodium chloride in 100 ml ofwater.
Stability of solutions
Solutions and II should be stored either in a refrigerator
at 4C or in a freezer at -20C. Solution III can be
stored at4C or 20C (see Appendix A). No measureable
decrease in catalytic activity of lactate dehydrogenase in
serum pools is observed when reagent II and III are stored
at 4C for at least 12 days. At room temperature
(20-25C) bacterial contamination of solutions I and II
is a limiting t;actor.
Measurement conditions
Wavelength" 339 nm (__ nm).
Bandwidth: < 2 nm.
Light path" 10"0 ___
0"01 mm.
Final volume of reaction mixture: 3" 15 ml.
Temperature: 30"0 +_ 0"05C (thermostated cuvette com-
partment).
Handling of solutions
Before solutions can be pipetted, the temperature of
reagent solutions and of specimen must be brought to
the calibration temperature of the pipettes. However,
use of other temperatures results in a relative error of
only 0"000025 for each C difference from the pipette
calibration temperature and for most situations this error
is negligible.
During the preincubation period the solution in the
cuvettes must attain a temperature of 30"0 +__ 0"05C
before initiating the reaction.
Procedures that constitute one measurement
Kind of reactions
Table 1. Composition of reaction mixtures A, B, and C
neededfor one measurement of rate of conversion.
Kind of reaction Sample Solution
(a) Overall reaction Serum II and III
(b) Reagent blank Reagent grade II and III
reaction water
(c) Sample blank Serum and III
reaction
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Overall reaction
Table 2. Analytical system for measurement of the overall rate of conversion.
Pipette into the
cuvette Volume
Substance concentration in final
complete reaction mixture
Solution II 2"70 ml N-methyl-D-glucamine 325 mmol/1
Lithium lactate 50 mmol/1
Serum 0" 15 ml Volume fraction "21
Mix carefully, avoiding the loss of any volume of the mixture. Incubate the reaction
mixture at 30C and wait for a minimum of 180 for temperature equilibration. Before
the following step, solution III should be at 30C.
Solution III 0.30 ml NAD
/ 10 mmol/1
Mix again and wait 30 s. Monitor the increase in absorbance at 339 nm as a function of
time, for at least an addition time of 240 s.
Reagen! blank
The same procedure as described above in table 2 is
tbllowed for the measurement of the reagent blank
reaction except that reagent grade water is substitued for
serum. The reagent blank is approximately 0"05 gkat/1
(3 U/).
Sample blank
A sample blank is determined for each sample by
substituting solution I for solution II and following the
same procedure as described above in table 2. Experi-
mental evidence has shown that the sample blank can be
up to 10% of the total catalytic activity. However, this
appears to be due to lactate present in the sample (see
Appendix A) and thus does not enter directly into the
calculation ofthe results (see below: ’Corrections for blank
reactions’).
Measurement inlerval
The values of A/s of the overall lactate dehydrogenase
reaction (A) are constant over a period of at least 240
tbr sera with catalytic concentration of lactate dehydro-
genase up to 10 ukat/1 (600 U/l). Occasionally, the value
ofA/s may not be constant over the time period, however,
if the conditions as described are tbllowed, this is
insignificant. If the absorbance change is greater than
0"0030/s, the serum sample must be diluted with solution
IV and the measurement repeated. The period of
observation of the blank reactions should be the same as
tbr the overall reaction.
Correclions for blank reactions
The rate of the overall reaction (A) is corrected for the
reagent blank value (B) as follows:
acorrected aa aB
The subscripts A and B refer to the composition of the
reaction mixtures referred to in table 1. The corrected
value of a is used in the following calculations. It equals
the true rate of conversion catalyzed by lactate dehydro-
genase.
The same blank does not enter into the calculations as it
is considered to be due to the presence of lactate in the
sample (see Appendix A). The amount of lactate
contributed by the serum sample to the overall lactate
concentration in the reaction mixture does not affect the
rate of conversion by lactate dehydrogenase.
Calculation
The molar absorption coefficient, of NADH (30C,
339 nm) is 630 m;/mol [7, 8-]. The light path length,
1, is 0"01 m (-10 mm). Let the increase in absorbance
per second at 339 nm be a/s. The total volume, V, is
3"15 10-31. The sample volume, v, is0"15 x 10-31.
ba
3"15 x 10 .3 s- 11
630.0"01.0"15 x 10 .3 m2.mol-l.m.1
3"15 Mol
0"945 M-
3
-1
a. 3"333 mol.
-3 a. 3"333 kat. m
a. 3333 gkat/1
Note, this value was calculated for a measuring time of s.
Let the increase in absorbance per 60 at 339 nm be
A. (60 s)-
b A. 3333 umol. (60 s)- .1-x
A.33 U/
Analytical variability
The intra-batch imprecision of the method has been
determined by repeated measurement at three LD levels
(table 3).
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Table 3. Intra-batch imprecision.
Sample Number Mean S.D. CV (%)
Low 20 137"9 1"33 0"96
Medium 18 310"0 2"98 0"97
High 20 469"9 4"58 0"97
An international transferability study is being undertaken.
Reference ranges
Reference ranges at 30C have not been determined for
this method. However, a reference range has been
determined at 37C on healthy people selected from
recruiting/entrance examinations at the Medical Univers-
ity of Lfibeck, Germany. The results are shown in table
5 of the Appendix.
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Appendix A: Description of pertinent factors in
obtaining optimal conditions for measurements
Introduction
After considerable discussion, the IFCC Committee on
Enzymes decided that because of the clinical importance
ofthe heart specific isoenzyme, LD 1, the refirence method
tbr lactate dehydrogenase would be optimized for this
isoenzyme. However, we are mindful that this method
will also be used to measure the other isoenzymes oflactate
dehydrogenase, and, although the method is not necessarily
optimized tbr these, it is still suitable tbr use in their
measurement. The other decision that was made was that
the pret>rred reaction direction to be assayed was from
lactate to pyruvate. Many workers have shown that the
lactate dehydrogenase reaction curve is curvi-linear;
however, the lactate to pyruvate reaction is less curved
[-1, 2] than the pyruvate to lactate reaction and should be
suitable for meaningful kinetic experiments. In addition,
the lactate to pyruvate reaction results in an increase in
absorbance and is less susceptible to substrate inhibition
[3]. A number of groups have also presented preliminary
results to the Committee on Enzymes suggesting that there
were problems in optimizing the pyruvate to lactate
reaction including unusual kinetics (two Km values tbr
pyruvate) and difficulties in interpreting the Surface
Response Optimization data.
This Appendix is a review of the various alternatives
considered in choosing the final conditions. These
experiments have been carried out using either serum,
LD1 prepared from serum using the Roche Isomune LD
kit, serum from patients with heart disease (LD1 serum)
or liver disease (LD5 serum) or LD1 and LD5 prepared
from human tissue using the method of Clark el al. [4].
All experiments described have been carried out at 30C
unless otherwise stated.
The experiments described in this Appendix have been
carried out at buffer concentrations of 150, 250 and
325 mmol/1. A buffer concentration of 150 mmol/1 was
used in some early experiments to determine the optimal
pH and kinetic constants. Other experiments were per-
formed using a buffer concentration of 250 mmol/1. Re-
sults available later from the Response Surface Optimiza-
tion analyses indicated an increase in buffer concentration
to 325 mmol/1 was necessary to achieve optimal assay
conditions. Although there was a slight increase in
buffering capacity at 325 mmol/1, little change in lactate
dehydrogenase activity was found. However, many
experiments previously performed using a 250 mmol/1
buffer concentration were repeated at the optimal concen-
tration of 325 mmol/1 in order to verify that there was no
change in the optimal concentrations of each reaction
component.
Buffer selection
Previous work by Buhl el al. [5], the Deutsche Gesellschaft
fr Klinische Chemic (DGKC) in Germany and by
members of the Committee on Enzymes examined a
variety of buffers that could be considered as suitable
the LD1 assay. These experiments included pH profile
studies and examining the linearity of the reaction
progress curve. From these studies, we concluded that
the buffers that warranted further consideration were
diethanolamine (DEA), 2-amino-2-methyl-l-propanol
(AMP) and N-methyl-D-glucamine (NMG). SEA was
not chosen because it can act as a substrate for alcohol
dehydrogenase (up to 38 of the activity compared with
using ethanol as the substrate) which can be present in
some sera at high concentrations [6]. This activity can
be substantial and give falsely elevated results. In some
publications, this activity has been erroneously referred
to as ’LD6 activity’ [7-10]. Although this is also a
problem with AMP (up to 20 of the alcohol dehydro-
genase activity measured with ethanol as the substrate),
this buffer has been compared with NMG because it has
been recommended by the DGKC as the buffer of choice
[].
Blank reactions
In experiments by the DGKC, NMG was rejected because
it gave a blank reaction whereas AMP did not. We have
repeated these experiments and initially measured the
blank reaction of the reagent in the absence of sample
(figure 1).
These reaction rates represent a blank of 0"02 l,tkat/k
(1"4 U/l) for AMP and 0"04 pkat (2"6 U/l) for NMG. In
both cases the blank would be considered insignificant
when routinely measuring the total lactate dehydrogenase
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Figure 1. Blank reactions with NMG buyer (B) and AMP
buffer [] ). The reaction conditions were such that when lhe various
components were combined theLfinal concenlrations were 325 mmol/1
bu,er, pH 9"4, 50 mmol/1 lithium lactate and 10 mmol/1 NAD +.
Waler was substitutedfor sample and the reaction was measured
al 30C.
activity although they should be measured when assigning
values to reference material.
Sample blank
The sample blank was measured with NAD + omitted
from the reaction mixture (figure 2).
As can be seen in figure 2, there was no significant reaction
with either NMG or AMP buffer.
The rate with NAD + included in the reaction but lactate
omitted was then measured (figure 3). Although lactate
was omitted, there was a significant blank reaction with
both buffers giving similar results. It is postulated that
0.25
0.20
J
0,15
0.10 "1--’ ’1 "’ "" ’1
2 3 4 5 6 7 8
Time [min]
Figure 2. Sample blankfor serum conlaining predominanlly LD1
omilled’om lhe reaction mixlure. The reaclion condilions were
2,50 mmol/1 b@r, pH 9"4, 50 mmol/1 laclale and ./VAD + omitted.
The reaclion was initiailed by adding sample.
0.75
0.70
0.85
0.60
0.55
0.50
0 2 3 4 5 6 7 8
Time [min]
Figure 3. Sample blank,/br serum conlaining predominanlly LD1
wilh NMG buffer and AMP buffer [] wilh laclate
omilledfrom the reaclion mixture. The reaclion mixlure was lhe
same as described in figure 1 except lhal laclale was omitted. The
reaction was initiated by adding 2VAD +.
this reaction is due to the presence of lactate in the sample
(normal range for lactate in serum is 0"2-2"0 mmol/1).
This was confirmed by adding oxamate (which is a specific
inhibitor of lactate dehydrogenase) to the reaction
mixture [ 12-1. At an oxamate concentration of100 mmol/1,
the reaction as described in figure 3 (that is in the absence
ofadded lactate) was effectively eliminated. This indicates
that lactate dehydrogenase is responsible tbr this blank
reaction and must be acting on endogenous lactate present
in the sample. It does not preclude, however, lactate
dehydrogenase acting on another substrate present in the
serum, but we feel this is unlikely given the specificity of
this enzyme.
Because the amount of lactate contributed by the sample
is insignificant compared with the concentration oflactate
already present in the assay mixture, its effect on
measuring total lactate dehydrogenase activity will be
negligible.
Effect of temperature on buffer pH
Although the reiierence method is being optimised at 30C,
many laboratories will be carrying out their assays at 37C
and thus we have studied the effect of temperature on the
pH of the buffer (figure 4). This is also important because
buffers are often prepared at a particular temperature and
then used at another. If the effect of the temperature on
the pH was not taken into account, the final assay pH
would be incorrect.
It was calculated t?om the results that NMG changes
0"016 pH units per C and AMP 0"021 pH units per C
indicating that AMP is affected slightly more by changes
in temperature than is NMG.
The results of these experiments show there is little
difference berween NMG and AMP. However, NMG is
pretierred as it is a non-toxic, white crystalline powder
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Figure 4. Effect of temperature on the pH ofNMG (B) and
AMP ([2) buyer. The concentration of each buffer was
325 mmol/l.
and is thus more easily handled than AMP. Also, NMG
does not act as a substrate for alcohol dehydrogenase as
is the case for AMP. The properties ofNMG as a buffer
have been discussed previously in relation to alkaline
phosphatase ]- 13].
Optimum pH
To determine the optimum pH of lactate dehydrogenase,
the activity was measured between pH 8"0 and 11"0.
Preliminary experiments showed that the optimum pH
for LD1 was greater than pH 10. However, because the
method would also be used for the measurement of other
isoenzmes besides LD1 and because of the increased
instability of NAD + at higher pH values, this pH was
600
500
400
300
200
100
0
8.0 8.5 9.0 9.5 10.0 10.5 11.0
pH
Figure 5. Effect of varying pH on the activity of lactate
dehydrogenase at 30C. The reaction was carried out al the
following concentrations, buffer, 150 mmol/l; NAD +, 10 mmol/l
and lactate, 50 mmol. The reaction was initiated by the addition
of NAD +. The samples that were assayed were purified LD1
(1), purified LD5 & ), a specimum containing predominantly
LD1 [] and a specimen containing predominantly LD5 A ).
400
aoo-
200
I00
0
8.8 9.0 9.2 9.4 9.6 9.8 10.0
pH
Figure 6. Effect of varying the pH between 8"9 and 9"9 on the
activity of lactate dehydrogenase activity measured at 30C. The
concentration of the reaction components were as described infigure
5 and the reaction was initiated by the addition ofNAD +. The
samples assayed were purified LD1 I ), purified LD5 l ), a
specimen containing predominantly (LD1) [] and a specimen
containing predominantly LD5 2x ).
considered to be too high for general use. In addition, we
demonstrated that LD5 was unstable at pH values greater
than 9"6.
The pH profile has been examined using purified LD1
and LD5 and serum containing predominanelty LD1
(LD serum) and another containing predominantly LD5
(LD5 serum).
As can be seen from these results, the pH optimum is
different for the various samples that were assayed (figure
5). Both purified LD5 and the serum containing LD5
reach a definite optimum between pH 9"2 and 9"5. Purified
LD1 and the serum containing LD1 almost reach an
optimum in the same region but then at pH values greater
than 9"6, the activity increases again reaching a true
optimum at 10"3. However, pH 10"3 is incompatible with
the stability of NAD
/ and, therefore, not suitable for
consideration as the assay pH. At pH values greater than
10"5, the activity of LD1, and the two serum samples
decrease rapidly probably due to the instability ofNAD
/
and the enzyme itselfat these high pH values. The purified
LD5 is unstable at considerably lower pH values. The
region between 9"2 and 9"5, in which the activity for all
the isoenzymes only increases gradually, was investigated
in greater detail.
To investigate this pH region, a similar experiment as
described above was carried out except that the pH range
being investigated was restricted to between 8"9 and 9"9
(figure 6). The reaction was initiated by the addition of
NAD
/ and the pH profiles of purified LD and LD5 and
serum containing either predominantly LD1 or LD5
investigated.
The results show there is little change in the activity of
the four samples when assayed between pH 9" 15 and 9"55.
The choice of 9"40 0"05 at 30"0 __
0"05C as the assay
pH lies within this range. Above pH 9"60, the activity of
LD1 increases significantly, whereas there is a decrease
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Figure 7. Effect of varying the pH between 8"9 and 9"8 on the
activily of lactate dehydrogenase aclivily measured al 37C. The
concentralion of the reaction components were as described infigure
5 and the reaction was initiated by the addition ofNAD +. The
samples assayed were purified LD1 (B), pured 1.1)5 (at), a
specimen containing predominantly LD1 ([]) and a specimen
containing containing predominantly LD5 A ).
in the activity of purified LD5. The serum tbrm ofLD5 is
much more stable and maintains its activity up to a pH
value of 9" 75.
Although the IFCC chose 30C as the assay temperature
fi)r its methods, many national societies have recommended
37C as the preferred assay temperature. This is now the
most widely used temperature for the routine assay of
enzymes. The effect of pH on the activity of lactate
dehydrogenase at 37C was also investigated but only
over the narrow pH range of 8"9 to 9"8 (figure 7).
The results at 37C show that there is little change in
activity tbr purified LD1, serum LD1 and serum LD5
when assayed between 9"20 and 9"45. Again, for LD1
there is a significant increase in activity above pH 9"55.
"Fhe loss of activity of purified LD5 occurs at a lower pH
but this may be due to the increased sensitivity of the
enzyme to the higher assay temperature used. No such
loss in activity occurs with serum LD5. Its activity, by
comparison, is stable over the wide pH range of 9"00 to
9’55. It should be noted, however, that the protein
concentration of the purified LD5 used in this experiment
is much lower than that present in serum and this may
contribute to the decreased stability.
Commenls on lhe pH optimum
The broad pH profile at 30C (figure 5) indicated that
the optimum tbr LD in both serum and the purified form
was 10"3. The activity increased steadily with the
increasing pH until pH 9"6, above which there was a sharp
increase in activity until pH 10"3. Above this value, the
activity dropped rapidly to zero either due to the
instability ofNAD + at very alkaline pH or the instability
ot" the enzyme itself. The optimum pH tbr LD5 in both
serum and the purified form was between 9"2 and 9"5. At
pH values greater than 9"6 the activity decreased
significantly, reaching zero by 10"5 and 10"8 for the
purified and the enzyme in serum, respectively.
The experiments using the narrow pH range at both 30C
and 37C contributed to the selection of a suitable assay
pH value. In these experiments, LD1 in both the purified
and serum forms exhibited a small increase in activity
with pH until 9"60 above which the increase was more
rapid. The patterns were similar at both assay tempera-
tures. At 30C, the smallest incremental change was
between pH 9"40 and 9"55 and at 37C the smallest
incremental change was between pH 9"20 and 9"45. The
optimum pH for LD5 in both serum and the purified
form at 30C was between 9"20 and 9"50. At 37C, the
LD5 in serum was stable within this pH range but the
purified form lost activity at pH values greater than 9"40
probably due to both the inactivation of the enzyme at
the more alkaline pH values and the greater heat
sensitivity of the LD5 isoenzyme at the higher assay
temperature.
From the above results, we concluded that the most suilable pH
value for the assay of lactate dehydrogenase is 9"40. This value
falls within the pH range where the activity of LD1 has
the smallest incremental change, is included in the
optimum pH range for LD5 and is close to the pKa value
of 9"6 for the NMG buffer. It also is the same as the
optimum pH selected independently by the DGKC [11].
Buffer concentration
To determine the optimum buffer concentration, the
concentration ofNMG buffer at pH 9"4 was varied in the
assay and the activity measured (figure 8). Initially, this
experiment was carried out at 30C using samples
consisting of purified LD1 and LD5 and serum which
contained predominantly either LD1 and LD5.
From this experiment, it can be seen that a buffer
concentration of 325 mmol/1 is suitable for use in the assay
800
500
400
300
20O
100
0
0 100 200 300 400
N-Methyl-D-glucamine [retool/l]
Figure 8. Effect of buffer concentration on the activity of lactate
dehydrogenase at 30 C. The samples that were assayed were purified
LD1 ), purifiedLD5 at ), a specimen containing predominantly
LD1 and a specimen containing predominantly LD5 ).
The subslrate concentrations were 50 mmol/1 lactate and 10 mmol/1
NAD +. The assay was initiated by the addition ofNAD +.
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Figure 9. Effect of busffer concentration on the activity of Lactate
dehydrogenase at 37 C. The samples that were assayed were purified
LD1 ), purified LD5 ,I ), a.specimen containing predominantly
LD1 ([]) and a specimum containing predominantly LD5 ).
The substrate concentrations were 50 mmol/1 lactate and 10 mmol/1
jVAD + The assay was initiated by the addition ofNAD +.
of lactate dehydrogenase. In addition, the same experi-
ment, although using different serum specimens, was
carried out at 30C (figure 9). This showed that
325 retool/1 is also a suitable buffer concentration at this
temperature. Other experimental work carried out to
determine the effect of substrates on the pH value of the
buffer also indicated that at this concentration, changes
in pH are minimal.
JEffec! of lemperalure oj bqffer preparalion on assay pH
As was shown previously, varying the temperature has an
efl’ect on the pH of the buffer. This means that the final
pH value at 30C or 37C will depend on the temperature
at which the buffer is prepared. Although buffers should
be prepared at the temperature at which the assay is to
be carried out, in practice they are often prepared at room
temperature (24C). We have fbund that fbr the assay to
be carried out at pH 9"40 at 30C and 37C, the buffer
needs to be prepared at room temperature at pH 9"50
and 9"63, respectively.
0.30
0.25
0.20
m 0.15
o O.lO
0.05
0.00
200 250 300 350 400
N-MethyI-D-glucamine [mmol/I]
Figure 10. Effect ofbuffer concentration on thepH change at 30C
and 37 C.
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Figure 11. Effect of increasing the sample volume fraction on the
activity of lactate dehydrogenase at 30 C. The sample assayed was
a serum containing predominantly LD1 ().
there is little effect of the sample volume fraction on the
assay between 0’03 and 0"08 and that 0"05 (1"21) is
suitable for use in this assay.
tfffec! oJ bu,ffer concenlralion on pH
It is important that the change in pH due to the effect
ot" temperature and the addition of reaction components
is kept to a minimum. We have tested this by preparing
the buffer at various concentrations, incubating at both
30C and 37C and monitoring the change due to the
addition of the reaction components (figure 10).
The results show that at a concentration of 325 retool/1
NMG, the change in pH is at a minimum.
Sample slabilily
To determine the stability of lactate dehydrogenase in
serum when incubated at pH 9"4, the enzyme was
incubated in NMG buffer for time intervals ranging from
0 to 25 rain. At the end of each incubation, the activity
was measured by adding the other assay components.
Both serum containing predominantly either LD1 and
LD5 were rested at 30C and 37C (figure 12). Both
samples showed no change in activity with time indicating
that the enzyme was stable under these conditions.
Sample volume jiaclion
The sample volume f?action optimum fbr the lactate
dehydrogenase assay was determined by assaying increas-
ing amounts of enzyme. The results (figure 1) show that
Slabiliy ofNAD +
One of the factors in assaying lactate dehydrogenase is
the stability ofNAD +. We have studied this by preparing
NAD + in various solutions and then measuring the effect
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Figure 12. Stability oflactate dehydrogenase in 325 mmol/lNMG
buffer, pH 9"4. Samples were incubated at either 30C (filled
symbols) or 37C (open symbols) .and then removedfor assay at
selecled times. The samples were serum which containedpredomin-
antly either LDI B, D) or LD5 (I, /).
as the pH is less than 6"0. Above pH 7’0, NAD
/ begins
to decompose causing an increase in the absorbance of
the solution and a decrease in activity of the lactate
dehydrogenase reaction. Our results also indicate that
there is no difference in stablity when the NAD
/ is
prepared in NMG buffer, imidazole buffer or water. For
ease of preparation, we recommended using an aqueous
solution ofNAD /.
Note. The pH ofan aqueous solution of 100 mmol/1NAD +
is 2"81 only when the NAD
/ is in the free acid form. If
the lithium salt ofNAD
/ is used, the resulting pH of the
solution may preclude its use in this assay.
Effect of reaction initiation
It has been recommended that the reaction be initiated
using NAD
/ because this minimizes the non-linearity
of the reaction curve. We have also tested the effect
of initiating the reaction with either sample or lactate
and have shown that this does not significantly alter
the measured activity when using the recommended
conditions.
of storage at 4C on the change in absorbance of the
solution and the effect on enzymic activity. Besides
choosing various concentrations of NMG, imidazole was
also tested because this was recommended by the DGKC
as the buffer ofchoice for preparing NAD /. All the buffers
were prepared to pH 9"50 at room temperature (24C)
and then the NAD
/ added to give a final concentration
of 100 mmol/1 NAD /. The resulting NAD
/ starting
solutions had pH values of 9"00 for 417 mmol/1 NMG,
7’95 for 275 mmol/1 NMG, 5"38 for 250 mmol/1 NMG,
4"24 for 200 mmol/1 NMG, 3’53 for 100 mmol/1, 6"03 for
100 mmol/1 imidazole and 2"81 for water.
The results (figures 13(a) and (b) show that the NAD +
reagent remains stable for at least 12 days at 4C as long
Determination of K for NAD + and lactate
In the assay of most enzymes, the concentration of the
substrates are chosen so that they are saturating. This is
normally done by determining the K values of the
substrates and then using concentrations > 20 K (at this
concentration of substrate, the catalytic activity should
be greater than 95 of the theoretical maximum). The
K values for the substrates have been determined using
zero order kinetics. To determine theK values forNAD
/
and lactate, the NAD + concentration was varied at fixed
concentrations of lactate.
The experiment was carried out at 30C on the Cobas
3.0
1.5
1o0
0.5
0.0
0 2 3 4 5 6 7 8 9 10 11 12 13
Days
/a)
500
400
300
200
100
0
0 2 3 4 5 6 7 8 9 10 11 12 13
Days
Figure 13(a) and (b). Effect of various solutions on the stability ofNAD + as measured at 339 nm (a) and the effect of these NAD +
solutions on the activity oflactate dehydrogenase (b). The solutions in which NAD + was prepared were 417 mmol/1 3/MG , 275 mmol/l
jYMG [] 250 mmol/1NMG A, 200 mmol/lNMG 100 mmol/l NMG, 0 ,100 mmol/l imadazole and water x. The absorbance
al 339 nm was measured using a 1 in 10 dilution of each NAD + solution. Solutions were stored at 4C.
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Figure 14. Activily projlesfor LD1 showing the eect of varying
/VAD + concentration atjxed concentrations of lactate. The lactate
concentrations were 1"5 mmol/1 . ), 2"0 mmol/1 C ), 3.5 mmol/1
& ), 5 mmol/1 / ), 7"5 mmol/1 , ), ZO mmol/1 (+) and
20 mmol/1 + ). The b@r concentration used in these experiments
was 150 mmol/1 NMG, pH 9"4.
Bio. The buffer/lactate solution was incubated with
purified LD1 for 3 min, after which time the NAD + was
added and the reaction monitored between 40 and 200
seconds. This short time period was chosen to ensure that
the reaction was monitored over a linear portion of the
reaction. The plot of the initial reaction velocity versus
the NAD + concentration at varying levels of lactate are
shown in figure 14.
This data can then be transformed into reciprocals and
replotted as shown in figure 15.
The replot gives a series of straight lines which intercept
at a single point. This is the expected pattern tbr a
sequential mechanism tbr a bireactant system. Implicit in
this mechanism is that all substrates must be present
-6 -4 -2 0 2 4 6 8 10
1/[HAD [l/mmol]
Figure 15. Double reciprocal plots of the data jor L1)I shown in
figure 14. The lactate concentrations were l"5 mmol/1 ),
2"0 mmol/1 [] ), 3"5 mmol/1 i ), 5 mmol/1 / ), 7"5 mmol/1
), 10 mmo[/1 (< and 20 mmol/1 + ).
simultaneously at the active site of the enzyme before
product formation can occur.
The rate equation describing this mechanism is:
VmaxAB (1) K’aKb + KbA + KaB + AB
When 1Iv is plotted versus 1/A (where A is the NAD +
concentration and B the lactate concentration) the plot
will be a series of straight lines described by the following
rate equation:
1Iv K’Kb +-+- + (2)
Vmax\ AB B A
Although the various constants described in equation 2
can bc determined by rcplotting the slopcs and intercepts
from the double reciprocal plot, in this case the data was
fitted to a reiterative computer program which was ablc
to fit the data to equation 2 [14]. From this, the following
valucs wcrc obtained:
K,.tt: 2"0 0"4 mmol/1
KNAD+ 0" 18 0"03 mmol/1
From these kinctic constants, suitable concentrations for
optimal activity would bc 40 retool/1 tbr lactate and
3"6 mmol/1 tbr NAD + (20 x Km), which compares
tvourably with the selected assay concentrations of
50 retool/1 and 10 mmol/1, respectively.
Wc have also carried out similar experiments with purified
LD5 (figures 16 and 17).
These data wcrc rcplottcd in thc double reciprocal tbrm
(figure 17) and analysed as dcscribcd for LD1.
Whcn fitted to equation (2), thc following kinetic
parameters wcrc obtained:
K,.t,t 5"6 1"2 retool/1
KNA+ 0"22 0"06 mmol/1
3OO
250
t
100
50
O .r,!
0 2 3 4 5 6
NAD [mmoi/l]
Figure 16. Activity profiles/or LD5 showing the eect of varying
NAD + concentration atfixed concentrations of lactate. The lactate
concentrations were 1"5 mmol/1 ), 2"0 mmol/l C] ), 3"5 mmol/1
& ), 5 mmol/1 / ), 7"5 mmol/1 ), ZO mmol/1 C> and
20 mmol/1 + ). The buyer concentration used in these experiments
was 150 mmol/1 NMG, pH 9"4.
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Figure 17. Double reciporcal plots of the data for LD5 shown in
figure 16. The lactate concentrations were l’5mmol/1 (.),
2"0 mmol/1 [ ), 3"5 mmol/1 l ), 5 mmol/1 A ), 7"5 mmol/1
(.), 10 mmol/1 and 20 mmol/1 + ).
The K,, value for NAD + obtained tbr LD5 is slightly
greater than that obtained tbr LD1 (0"22 mmol/1 compared
to 0" 18 mmol/1) whereas the K for lactate is considerably
greater (5"6 mmol/1 compared to 2"0 mmol/1). Thus, to
achieve the theoretical maximum catalytic activity
LD5, a lactate concentration of greater than 100 mmol/1
would be required.
From previous work and that of others, it is clear that the
lactate to pyruvate reaction is curvi-linear. The main
reason for non-linearity is thought to be the formation of
dead-end complexes during the reaction as depicted in
the following mechanism [15]:
E E-NADH ---
E-NADH-Pyruvate
E-NADH-Lactate
.---- E-NAD-Lactate E-NAD E
E-NAD-Pyruvate
E-NADH-lactate and E-NAD-pyruvate are dead-end
complexes. The tbrmation of these dead-end complexes
also suggested that using 20 x K as the optimum
substrate concentration may compromise the activity,
because a greater concentration of substrate would be
required to saturate due to the amount bound up in the
dead-end complex.
This proposal was tested by fixing the lactate concentra-
tion at 50 mmol/1 and measuring the activity at varying
NAD + concentrations. This was carried out at both 30C
and 37C to determine whether the temperature has an
effect on the concentration required for maximum
activity (figure 18).
The results shows that the formation of the dead-end
complexes have an effect on the NAD
/ concentration
required for saturation. Using the Km value determined
for NAD
/ in the previous experiments it would be
expected that a concentration of 5 mmol/1 (>20 Km)
would be optimal. However, as can be seen in figure 18,
this is not the case and a significantly greater concentra-
tion is required.
A concentration of 10 mmol/1 2VAD + was selected as @limal.
A similar experiment was carried out to determine
whether the kinetics of the enzyme reaction has an effect
on the concentration of lactate required for optimal
activity (figure 19).
The results indicate that a concentration of 50 mmol/1 is
optimal for LD1 both in the serum and purified tbrm,
which agrees with the results obtained from previous
kinetic experiments. Above this concentration, there is
substrate inhibition. As can be seen in figure 19, this
concentration is also optimal for LD5 in serum but for
purified LD5, a lactate concentration greater than
100 mmol/1 would be required. Even though a lactate
concentration of 50 mmol/1 is sub-optimal for purified
LD5, the activity obtained is still greater than 90?/o of the
maximum.
A lactate concentration of 50 mmol/1 was selected as optimal.
Response Surface Optimization
The conditions for the measurement of lactate dehydro-
genase have also been investigated using Response Surface
Optimization [16]. This technique requires simultaneous
variation ofthe component concentrations with subsequent
computer analysis of the responses obtained at the defined
reaction conditions. Factorial experimentation at varying
pH, buffer concentration, NAD + and lactate concentra-
tions were conducted at 30C using sera containing either
predominantly LD or LD5. Theoretical response surfaces
were computed by fitting a second-order polynomial
equation using least squares regression analysis techniques.
The data were analysed independently by two laboratories
(Service de Biochimie, Hopital Debrousse, Lyons, France
and the Reference Laboratory, Eastman Kodak Company,
Rochester, New York, USA). The results from the
response surface optimization experiments are shown in
figure 20 (LD1) and 21 (LD5) and the results from the
two laboratories are summarized in table 4.
The analysis showed there is a range of concentrations for
both lactate and NAD
/ which give little variation in LD
activity: This range is 26 to 50 mmol/1 for lactate and 10
to 16 mmol/1 for NAD /. The analysis also showed there
is a negative interaction between the optimal concentra-
tions of lactate and NAD+, that is, as the assay lactate
concentration is increased, the optimal concentration tbr
NAD + is lowered, and vice versa. Theretbre, at the chosen
lactate concentration of 50 mmol/1, the optimal concen-
tration for NAD + is 10 mmol/1 rather than 16 mmol/1. As
can be seen from the univariate experiment (figure 18),
an NAD
/ concentration of 10 mmol/1 is close to the
optimum. In addition, the reagent blank reading and the
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Figure 18. Effect of varying 2gAD + concentration at 50 mmol/1 lactate at 30C (a) and 37C (b). The samples assayed were purified
LD1 (M), purified LD5 (ll), a specimen containing predominantly LD1 (D) and a specimen containing predominantly LD5 A ).
The assay was initiated by the addition ofNAD +. The concentration of the NMG buffer was 325 mmol/1, pH 9"4. Different enzymes
samples were usedfor the experiments at 30C and 37C.
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Figure 19. The effect of varying lactate concentration at 10 mmol/1NAD + at 30C (a) and 37C (b). The reaction was initiated by the
addition ofNAD +. The samples that were assayed were purified LD1 ), purified LD5 & ), a specimen containing predominantly
LD1 (V) and a specimen containing predominantly LD5 ). The concentration of the NMG buffer was 325 mmol/1, pH 9"4. Different
enzyme samples were usedfor the experiments at 30C and 37C.
Table 4. Optimal valuesfor assay conditions as determined by surface response optimization.
LD1 LD5
Rochester Lyons Rochester Lyons Recommended
Buffer 303’5 310 273 340 325
pH 9’90 9"90 9"74 9"8 9"4
NAD + 15’2 16 11"7 13"6 10
Lactate 37"0 35 53"5 50 50
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Figure 20. Optimiazation of using RSO of pit, lactate and NAD
/ concentration for human serum containing predominantly LD1.
Values usedJor lhese experiments were pH (8"9, 9"4, 9"9), lactate concentration (20, 50, 80), NAD + (4, 10, 16) and buyer concentration
(100, 250, 400). IsoactiviZy contour lines are drawn al intervals of 2 U/l.
initial absorbance of the assay mixture are more accept-
able at the lower NAD + concentration of 10 mmol/1.
The RSO analysis defined that pH values between pH
9"7 and 9"9 were optimal for the assay. Unfortunately,
NAD + is unstable under these conditions, and therefore,
as explained previously, a value of 9"4 was selected as the
most practical value to use. Even with these compromises,
the assay still gives greater than 95 of the theoretical
optimal activity for both LD1 and LD5.
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Figure 21. Optimization using RSO ofpH, lactate and NAD + concentrationsfor human serum containing predominantly LD5. Values
used for these experiments were pH (8"9, 9"4, 9"9), lactate concentration (20, 50, 80), NAD + (4, 10, 16) and buffer concentration
(100, 250, 400). Isoactivily contour lines are drawn at intervals of 2 U/1.
Dynamic range
The assay dynamic range was determined by assaying a
specimen with high activity which had been diluted with
saline. The results (figure 22) show that the assay is linear
up to 600 U/1. Above this activity the specimen should be
diluted.
Reference interval
Reference ranges at 30C have not yet been deter-
mined tbr this method. However, a reference range has
been determined at 37C on healthy people selected
from recruiting/engagement examinations at the
Medical University of Lfibeck, Germany. The results
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Table 5. Reference ranges (U/l)for laclale dehydrogenase assayed at 37C.
Group 2V Range Mean 0"95-reference interval
All 136 132-228 172
Fcmales 74 133-226 172
Males 62 132-228 172
135-225
135-214
135-225
900
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o, 500
0
>" 400
(R) 300
o 200
100
0 I110 2110 3110 4110 5110 6110 7110 8110 9110
Dilution
Figure 22. Dynamic range of lactate dehydrogenase. A serum
sample wilh high aclivily was diluted wilh saline and lhe activity
measured.
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Figure 24. Comparison 02/"LD activity between 30C and 37C.
The assays were carried out on the Cobas Bio using the conditions
and concentrations as recommended.
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Figure 23. Distribution of lactate dehydrogenase activity for 136
heallhy people (74 females, 62 males assayed al 37C).
are shown in Figure 23 and are summarized in
table 5.
Conversion factor 30C to 37C
The factor for conversion of results between 30C and
37C was determined by assaying 48 specimens at each
temperature (figure 24). The specimens were selected for
those arriving in the laboratory and not tested for their
isoenzyme content. From the results it can be seen that
there is an excellent correlation between the recommended
method assayed at the two temperatures indicating that
it is suitable for use at both 30C and 37C. The conver-
sion is
(activity)37 1"596 (activity)30.
Although it is not recommended that factors be used
routinely to convert activities between different tempera-
tures, it does give an indication of their relationship.
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